
Patients who receive a diagnosis of spinal muscular atrophy (SMA) require an empathetic approach from their primary care physician when receiving the diagnosis and evaluating options, according to recent study findings.

Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.

Patients who receive a diagnosis of spinal muscular atrophy (SMA) require an empathetic approach from their primary care physician when receiving the diagnosis and evaluating options, according to recent study findings.

This new study from Iran investigated outcomes following treatment for pulmonary arterial hypertension (PAH) with macitentan compared with bosentan.

The development of 2 panels measuring levels of tumor-associated autoantibodies (TAAbs) has promise for predicting therapeutic response and adverse events for patients with advanced non–small cell lung cancer (NSCLC) after immune checkpoint inhibitor–based treatment.

This study investigated the effects of antimicrobial therapy among patients with non–small cell lung cancer (NSCLC) who received immunotherapy with a checkpoint inhibitor or chemotherapy plus immunotherapy (CIT).

New study findings show that internalized problems such as anxiety and depression were found at higher levels in children and infants who had a diagnosis of spinal muscular atrophy (SMA).

A clinical trial found that the prevalence of age-related macular degeneration (AMD) was not associated with the use of metformin.

The top 5 most-read content in ophthalmology for 2022 focused on the relationship between aging and visual field reliability, telehealth eye care visits, the link between COVID-19 and dry eye disease, and more.

Coverage of the annual meeting of the American Academy of Ophthalmology (AAO) included interviews with experts on thyroid eye disease and anti–vascular endothelial growth factor therapy, as well as breaking research.

A study found that depressive symptoms were associated with a sleep midpoint outside of 2:00-4:00 am.

The top 5 most-read articles about chronic kidney disease (CKD) focused on finerenone benefits, anticoagulants, dementia association, and more.

The most-read content in sleep this year included articles on narcolepsy, continuous positive airway pressure adherence, and new drugs approved for insomnia, among other stories.

Kidney Week 2022 focused on effectiveness of treatment for chronic kidney disease, health misinformation, and outcomes in chronic kidney disease, among other topics.

The most-read articles related to our Strategic Alliance Partnership (SAP) program focused on behavioral health, oncology care, and partner news.

Lower estimated tubular secretion was found to be associated with a faster decline of estimated glomerular filtration rate (eGFR) but wasn’t associated with progression of chronic kidney disease or cardiovascular disease.

The top 5 most-read articles about diabetes featured stories on FDA approvals, drug prices, and the effectiveness of vitamin D in diabetes prevention, among others.

A new study found that short sleep duration and high siesta ratio were associated with a higher risk of hypertension and elevated risk of cardiovascular diseases.

A new study has found that prolonged screen time may cause increased symptoms of dry eye disease (DED) in children.

A new study has found that Mexican Americans and non-Hispanic Black Americans had low rates of glycemic control compared with non-Hispanic White Americans.

A retrospective study found roxadustat to be more effective in improving hemoglobin levels in patients who had with chronic kidney disease (CKD) compared with recombinant human erythropoietin.

Identifying dementia could be easier by using a routine sleep EEG to incorporate dementia screening techniques.

The staff clinician group with access to the Enhanced Primary Care Diabetes model was found to improve their diabetes care quality.

Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD).

Patients who used a mandibular advancement device (MAD) to address their obstructive sleep apnea (OSA) symptoms reported improvement in their sleep quality and tiredness on waking even if their sleep criteria did not indicate a response to treatment, indicating the importance of a posttreatment sleep study to ensure MAD efficacy.

Prescriptions for treatment of atrial fibrillation (AF) and chronic kidney disease (CKD) have primarily been prescriptions for direct oral anticoagulants (DOACs), displacing warfarin as the primary treatment.

A new study found that people with type 2 diabetes had improved glycemic control and weight when on a low-carbohydrate, high-fat diet compared with a high-carbohydrate, low-fat diet.

A retrospective cohort study found that rapid thinning of the ganglion cell complex was associated with central visual field decline.

A cohort study found that chronic kidney disease (CKD) was associated with the development of abdominal aortic aneurysm, with risk increasing as CKD stage advanced.

The Sleep 2022 meeting from early June included talks on narcolepsy, the role of race in sleep disturbances, and the use of opioids in restless leg syndrome.

Patients with type 2 diabetes can determine their risk of chronic kidney disease (CKD) by using a risk prediction model.

Speaking with patients diagnosed with chronic kidney disease (CKD) about the burdens associated with care could help improve understanding of the disease and their communication with health care professionals.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
